Danaher Share Holder Equity 2011-2025 | DHR
Danaher share holder equity from 2011 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
- Danaher share holder equity for the quarter ending September 30, 2025 was $51.080B, a 0.44% decline year-over-year.
- Danaher share holder equity for 2024 was $49.55B, a 7.37% decline from 2023.
- Danaher share holder equity for 2023 was $53.49B, a 6.79% increase from 2022.
- Danaher share holder equity for 2022 was $50.09B, a 10.88% increase from 2021.
|
Danaher Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $49,550 |
| 2023 | $53,490 |
| 2022 | $50,090 |
| 2021 | $45,177 |
| 2020 | $39,777 |
| 2019 | $30,282 |
| 2018 | $28,227 |
| 2017 | $26,368 |
| 2016 | $23,077 |
| 2015 | $23,764 |
| 2014 | $23,450 |
| 2013 | $22,451 |
| 2012 | $19,084 |
| 2011 | $16,972 |
| 2010 | $13,773 |
|
Danaher Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-09-30 | $51,080 |
| 2025-06-30 | $52,342 |
| 2025-03-31 | $50,857 |
| 2024-12-31 | $49,550 |
| 2024-09-30 | $51,305 |
| 2024-06-30 | $49,902 |
| 2024-03-31 | $53,447 |
| 2023-12-31 | $53,490 |
| 2023-09-30 | $52,415 |
| 2023-06-30 | $51,724 |
| 2023-03-31 | $51,486 |
| 2022-12-31 | $50,090 |
| 2022-09-30 | $46,993 |
| 2022-06-30 | $46,601 |
| 2022-03-31 | $46,362 |
| 2021-12-31 | $45,177 |
| 2021-09-30 | $43,461 |
| 2021-06-30 | $42,766 |
| 2021-03-31 | $40,430 |
| 2020-12-31 | $39,777 |
| 2020-09-30 | $37,973 |
| 2020-06-30 | $36,273 |
| 2020-03-31 | $31,066 |
| 2019-12-31 | $30,282 |
| 2019-09-30 | $33,196 |
| 2019-06-30 | $32,213 |
| 2019-03-31 | $31,569 |
| 2018-12-31 | $28,227 |
| 2018-09-30 | $27,685 |
| 2018-06-30 | $27,224 |
| 2018-03-31 | $27,202 |
| 2017-12-31 | $26,368 |
| 2017-09-30 | $25,381 |
| 2017-06-30 | $24,595 |
| 2017-03-31 | $23,791 |
| 2016-12-31 | $23,077 |
| 2016-09-30 | $23,264 |
| 2016-06-30 | $25,120 |
| 2016-03-31 | $24,577 |
| 2015-12-31 | $23,764 |
| 2015-09-30 | $23,184 |
| 2015-06-30 | $24,172 |
| 2015-03-31 | $23,391 |
| 2014-12-31 | $23,450 |
| 2014-09-30 | $23,810 |
| 2014-06-30 | $23,789 |
| 2014-03-31 | $23,029 |
| 2013-12-31 | $22,451 |
| 2013-09-30 | $21,371 |
| 2013-06-30 | $20,365 |
| 2013-03-31 | $19,749 |
| 2012-12-31 | $19,084 |
| 2012-09-30 | $18,953 |
| 2012-06-30 | $18,368 |
| 2012-03-31 | $17,891 |
| 2011-12-31 | $16,972 |
| 2011-09-30 | $16,562 |
| 2011-06-30 | $16,556 |
| 2011-03-31 | $14,724 |
| 2010-12-31 | $13,773 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $159.868B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCA Healthcare (HCA) | United States | $110.622B | 18.31 |
| CVS Health (CVS) | United States | $100.818B | 11.59 |
| Elevance Health (ELV) | United States | $79.799B | 11.70 |
| Cencora (COR) | United States | $67.122B | 21.64 |
| Natera (NTRA) | United States | $32.084B | 0.00 |
| DiDi Global (DIDIY) | China | $23.674B | 21.87 |
| Labcorp Holdings (LH) | United States | $21.901B | 16.70 |
| Medpace Holdings (MEDP) | United States | $15.715B | 39.01 |
| ICON (ICLR) | Ireland | $15.068B | 14.95 |
| BioMerieux (BMXMF) | France | $14.825B | 0.00 |
| Solventum (SOLV) | United States | $14.393B | 13.97 |
| Viatris (VTRS) | United States | $13.418B | 5.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.123B | 0.00 |
| CochLear (CHEOY) | Australia | $11.455B | 0.00 |
| Revvity (RVTY) | United States | $11.393B | 20.98 |
| Charles River Laboratories (CRL) | United States | $9.500B | 18.30 |
| HealthEquity (HQY) | United States | $8.269B | 30.92 |
| Sonic Healthcare (SKHHY) | Australia | $7.631B | 0.00 |
| Avantor (AVTR) | United States | $7.616B | 11.64 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.550B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $6.590B | 39.29 |
| Bausch + Lomb (BLCO) | Canada | $6.018B | 39.51 |
| PACS (PACS) | United States | $5.449B | 33.13 |
| Sotera Health (SHC) | United States | $4.781B | 23.06 |
| GeneDx Holdings (WGS) | United States | $4.379B | 76.91 |
| Alignment Healthcare (ALHC) | United States | $3.874B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.508B | 20.47 |
| Concentras Parent (CON) | United States | $2.547B | 15.90 |
| Progyny (PGNY) | United States | $2.303B | 45.27 |
| Establishment Labs Holdings (ESTA) | United States | $2.107B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.022B | 26.05 |
| Pediatrix Medical (MD) | United States | $1.932B | 11.54 |
| Organon (OGN) | United States | $1.864B | 1.96 |
| Teladoc Health (TDOC) | United States | $1.340B | 0.00 |
| Nutex Health (NUTX) | United States | $1.308B | 10.00 |
| Ardent Health (ARDT) | United States | $1.259B | 4.11 |
| CareDx (CDNA) | United States | $1.057B | 17.28 |
| GoodRx Holdings (GDRX) | United States | $0.957B | 15.67 |
| Omada Health (OMDA) | $0.874B | 0.00 | |
| InnovAge Holding (INNV) | United States | $0.733B | 0.00 |
| Embecta (EMBC) | United States | $0.690B | 3.97 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.647B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.582B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| Enhabit (EHAB) | United States | $0.490B | 22.00 |
| CryoPort (CYRX) | United States | $0.471B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.442B | 0.00 |
| SBC Medicals (SBC) | United States | $0.429B | 7.89 |
| Oncology Institute (TOI) | United States | $0.372B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.338B | 5.43 |
| QDM (QDMI) | Hong Kong, SAR China | $0.323B | 67.42 |
| So-Young (SY) | China | $0.312B | 0.00 |
| Agilon Health (AGL) | United States | $0.298B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.296B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.188B | 0.00 |
| Beauty Health (SKIN) | United States | $0.179B | 0.00 |
| KindlyMD (NAKA) | United States | $0.176B | 0.00 |
| LifeMD (LFMD) | United States | $0.164B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.135B | 0.00 |
| DocGo (DCGO) | United States | $0.090B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.057B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.043B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.021B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.24 |
| Basel Medical Group (BMGL) | Singapore | $0.017B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.005B | 0.00 |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |